Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
hb0017 (3 trials)
capecitabine (xeloda) (1 trial)
carboplatin (paraplatin) (1 trial)
cisplatin (platinol) (1 trial)
gemcitabine (gemzar) (1 trial)
hb002.1m (3 trials)
hb0025 (1 trial)
hb0030 (1 trial)
hot-1030 (1 trial)
oxaliplatin (eloxatin) (1 trial)
paclitaxel (taxol) (1 trial)
Macular Degeneration (Phase 1)
Neoplasms (Phase 1)
Wet Macular Degeneration (Phase 1)
Trials (9 total)
Trial APIs (11 total)